Quick Answer
IO Biotech, Inc. reported Stockholders Equity of $47.02 million for fiscal year 2024.
IO Biotech, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2024 | $47.02M | -64.7% |
| 2023 | $133.16M | -4.1% |
| 2022 | $138.85M | -34.5% |
| 2021 | $211.92M | +700.3% |
| 2020 | -$35.30M | -50.0% |
| 2019 | -$23.53M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $911.0K | -98.7% | -42.8% |
| June 30, 2025 | $1.59M | -98.3% | -94.0% |
| March 31, 2025 | $26.42M | -77.1% | -43.8% |
| December 31, 2024 | $47.02M | -64.7% | -35.2% |
| September 30, 2024 | $72.56M | -54.0% | -24.6% |
| June 30, 2024 | $96.27M | -7.9% | -16.6% |
| March 31, 2024 | $115.47M | -7.0% | -13.3% |
| December 31, 2023 | $133.16M | -4.1% | -15.5% |
- IO Biotech, Inc. showed a decrease of -64.7% in Stockholders Equity compared to the prior fiscal year.
- Over the 2019–2024 period, IO Biotech, Inc.’s stockholders equity has grown by 299.8% (from -$23.53 million to $47.02 million).
- The most recent figure is from IO Biotech, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: